Voluntary clinical trials to examine the safety and efficacy of transdermal electrical stimulation intended for non-arteritic ischemic optic neuropathy - Transdermal electrical stimulation intended for NAIO

Chiba university Department of Ophthalmology0 个研究点目标入组 3 人开始时间: 2016年4月12日最近更新: 2023年10月17日

适应症

试验速览

暂无简介。

•Arteritic ischemic optic neuropathy patients Patients with vitreous macular traction syndrome, macular edema, macular lesions such as epiretinal mebrane Patients admitted the loss of vision caused by eye diseases other than ischemic optic neuropathy, the study director (sharing) doctor was ineligible Patients retinal vein occlusion, have merged the retinal artery occlusion Patients who are complicated by diabetic retinopathy Patients who are complicated by glaucoma History of optic nerve diseases other than ischemic optic neuropathy Inflammation of the external eye, the merger of the infection or severe dry eye Patients who use oral of Methycobal within 31 days, oral circulatory disorder improving drugs, oral platelet aggregation inhibitor, the drug or the like of oral corticosteroids (eye drops are excluded) Patients who underwent intravenous administration of prostaglandin E formulation within 31 days Patients who underwent a stellate ganglion block within 31 days Patients with unoprostone eye drops within 31 days Patients within three months a history of eye surgery Drug that you plan to use during the test period (ophthalmic anesthetic, mydriatics, etc.) with respect to, history of drug allergy Patients likely to have been pregnant or pregnant. Patients during breast-feeding. Patients who wish to become pregnant during the study period.

发起方

Chiba university Department of Ophthalmology